Bullish (BLSH) financials
NYSE · Technology · Software - Application · 414 employees · CEO Thomas W. Farley
- Price
- $23.90 -16.05%
- Market cap
- $3.62B
- Enterprise value
- $4.04B
- Last report
- Q2 '26 filed 2026-08-13
- Next report
- 2026-11-18 EPS est. $0.08
Valuation & key figures
- Market cap
- $3.62B EV $4.04B
- Revenue
- $158B Trailing 12 months
- Revenue growth
- – Next fiscal year
- Profit margin
- -0.9% Net income / revenue, TTM
- P/E
- -2.6×
- P/S
- 0.0× Price / sales, TTM
- EV / EBITDA
- -3.7× TTM
- Free cash flow
- $97M Trailing 12 months
- Net income
- -$1.38B Trailing 12 months
- Revenue estimate
- – Next fiscal year
- Earnings
- 2026-11-18 Revenue est. $79.6M
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-13): revenue beat by 5.9%, EPS beat by 14.2%Revenue $92.6M vs $87.4M expected (+5.9%); EPS $0.10 vs $0.09 (+14.2%).
- Revenue growth slowing: -99.8% year on yearQ2 '26 revenue $92.6M, against an average of -10.7% over the four quarters before.
- Operating margin -0.0% (TTM), 0.0 pp on a year agoOperating income grew -142.8% while revenue grew -39.1%.
- Capex 0.0% of revenue (a year ago 0.0%)$11.8M invested in the last 4 quarters (-73.9% on a year earlier). Free cash flow $97M.
- Diluted share count up 3.6% in a year151M diluted shares in Q2 '26, 146M a year earlier.
- Net debt $188MCash + short-term investments $330M, debt incl. leases $518M; a year ago net debt $28M.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $92.6M | $58.7B | -99.8% |
| Gross margin | 70.3% | 0.1% | +70.3 pp |
| Operating income | $6.11M | -$12.7M | +148.1% |
| Operating margin | 6.6% | -0.0% | +6.6 pp |
| Net income | -$270M | $108M | -351.3% |
| Diluted EPS | -$1.78 | $0.74 | -340.5% |
| Operating cash flow | $2.69M | $17M | -84.2% |
| Capex | $635K | $227K | +179.7% |
| Free cash flow | $2.06M | $16.8M | -87.7% |
| R&D | $0 | $0 | – |
| Stock-based compensation | $0 | $3.26M | -100.0% |
Reported vs consensus
2026-08-13| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $92.6M | $87.4M | +5.9% |
| EPS (as estimated) | $0.10 | $0.09 | +14.2% |
From the report of 2026-08-13 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $109M
- Capex
- -$11.8M
- Buybacks
- $0
- Dividends
- $0
- Acquisitions
- $9K
- Net debt issued
- -$51.1M
- Stock-based compensation
- $13.4M
- Free cash flow
- $97M
- Returned to shareholders / FCF
- -0.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | -2.6× | 66.8× 2 of 5 years | 7.6× – 125.9× |
| EV / EBITDA | -3.7× | 43.6× 2 of 5 years | 7.8× – 79.4× |
| EV / Sales | 0.0× | 1.6× | 0.0× – 7.5× |
| Price / FCF | 37.4× | 51.3× 1 of 5 years | 51.3× – 51.3× |
| Price / Book | 1.5× | 4.1× | 1.5× – 7.8× |
| FCF yield | 2.7% | -0.9% | -4.6% – 1.9% |
| Return on invested capital | -0.2% | -2.8% | -17.5% – 1.3% |
| Return on equity | -45.3% | -33.5% | -225.5% – 101.4% |
Analysts
Consensus target $44.00 (+84.1%)
range $30.00 – $61.00 · rating Buy
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-02